載入...
4CPS-104 Effectiveness and safety of cabazitaxel in castration-resistant metastatic prostate cancer
BACKGROUND: Prostate cancer is one of the most common cancers in Europe. Cabazitaxel, a tubulin-binding taxane drug as potent as docetaxel in cell lines, was the first treatment able to prolong survival for metastatic castration-resistant prostate cancer in the post-docetaxel setting. PURPOSE: Analy...
Na minha lista:
| 發表在: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Group
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535602/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.195 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|